Product cited in:
Tomlins, Rhodes, Yu et al.: "The role of SPINK1 in ETS rearrangement-negative prostate cancers." in: Cancer cell, Vol. 13, Issue 6, pp. 519-28, 2008 (PubMed).
Han, Mehra, Suleman et al.: "Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma." in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Vol. 22, Issue 9, pp. 1176-85, 2009 (PubMed).
Rink, Park, Volkmer et al.: "Loss of SPINK1 expression is associated with unfavorable outcomes in urothelial carcinoma of the bladder after radical cystectomy." in: Urologic oncology, 2012 (PubMed).
Bhalla, Kunju, Tomlins et al.: "Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma." in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Vol. 26, Issue 6, pp. 835-48, 2013 (PubMed).
Smith, Palanisamy, Zuhlke et al.: "HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey." in: The American journal of surgical pathology, Vol. 38, Issue 5, pp. 615-26, 2014 (PubMed).